Validity and reliability of new intravascular ultrasound analysis software for morphological measurement of coronary artery disease

Circulation Journal

Volumn 77, Issue 2, 2013, Pages 424-431

  Nakayama, Naoki ^a   Hibi, Kiyoshi ^a   Endo, Mitsuaki ^a   Miyazawa, Akiyoshi ^b   Suzuki, Hiroyuki ^a   Maejima, Nobuhiko ^a   Isshiki, Takaaki ^b   Kozuma, Ken ^b   Kimura, Kazuo ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b TEIKYO UNIVERSITY HOSPITAL   (Japan)

Author keywords

EchoplaqueTM; IVUS analysis software; Reliability; Validity; VISIATLASTM

Indexed keywords

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL DIAMETER; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORONARY STENT; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELASTIC TISSUE; FEMALE; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; MALE; MEASUREMENT REPEATABILITY; OBSERVER VARIATION; REPRODUCIBILITY; VALIDITY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; OBSERVER VARIATION; PHANTOMS, IMAGING; REPRODUCIBILITY OF RESULTS; SOFTWARE DESIGN; STENTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84873868229     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0630     Document Type: Article

References (25)

1. Nissen SE, Yock P. Intravascular ultrasound: Novel pathophysiological insights and current clinical applications. Circulation 2001; 103: 604-616.
2. Yock PG, Linker DT, Angelsen BA. Two-dimensional intravascular ultrasound: Technical development and initial clinical experience. J Am Soc Echocardiogr 1989; 2: 296-304.
3. Nissen SE, Gurley JC, Grines CL, Booth DC, McClure R, Berk M, et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991; 84: 1087-1099.
4. Tobis JM, Mallery J, Mahon D, Lehmann K, Zalesky P, Griffith J, et al. Intravascular ultrasound imaging of human coronary arteries in vivo: Analysis of tissue characterizations with comparison to in vitro histological specimens. Circulation 1991; 83: 913-926.
5. Alfonso F, Macaya C, Goicolea J, Iñiguez A, Hernandez R, Zamorano J, et al. Intravascular ultrasound imaging of angiographically normal coronary segments in patients with coronary artery disease. Am Heart J 1994; 127: 536-544.
6. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004; 291: 1071-1080.
7. Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: The CAMELOT study: A randomized controlled trial. JAMA 2004; 292: 2217-2225.
8. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006; 295: 1556-1565.
9. Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, et al. Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: Multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J 2009; 73: 2110-2117.
10. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: A multicenter randomized trial evaluated by volumetric intravascular ultra sound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol 2009; 54: 293-302.
11. Otagiri K, Tsutsui H, Kumazaki S, Miyashita Y, Aizawa K, Koshikawa M, et al. Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: Analysis using integrated backscatter IVUS (ELAN study). Circ J 2011; 75: 633-641.
12. Kovarnik T, Mintz GS, Skalicka H, Kral A, Horak J, Skulec R, et al. Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: HEAVEN study. Circ J 2012; 76: 176-183.
13. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002; 106: 2200-2206.
14. Kawasaki M, Takatsu H, Noda T, Ito Y, Kunishima A, Arai M, et al. Noninvasive quantitative tissue characterization and two-dimensional color-coded map of human atherosclerotic lesions using ultrasound integrated backscatter: Comparison between histology and integrated backscatter images. J Am Coll Cardiol 2001; 38: 486-492.
15. Sathyanarayana S, Carlier S, Li W, Thomas L. Characterisation of atherosclerotic plaque by spectral similarity of radiofrequency intravascular ultrasound signals. EuroIntervention 2009; 5: 133-139.
16. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS): A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001; 37: 1478-1492.
17. Kataoka T, Grube E, Honda Y, Morino Y, Hur SH, Bonneau HN, et al. 7-Hexanoyltaxol-eluting stent for prevention of neointimal growth: An intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE). Circulation 2002; 106: 1788-1793.
18. Ohota M, Kawasaki M, Ismail TF, Hattori K, Serruys PW, Ozaki Y. A histological and clinical comparison of new and conventional integrated backscatter intravascular ultrasound (IB-IVUS). Circ J 2012; 76: 1678-1686.
19. Hibi K, Takagi A, Zhang X, Teo TJ, Bonneau HN, Yock PG, et al. Feasibility of a novel blood noise reduction algorithm to enhance reproducibility of ultra-high-frequency intravascular ultrasound images. Circulation 2000; 102: 1657-1663.
20. Mintz GS, Griffin J, Chuang YC, Pichard AD, Kent KM, Satler LF, et al. Reproducibility of the intravascular ultrasound assessment of stent implantation in saphenous vein grafts. Am J Cardiol 1995; 75: 1267-1270.
21. von Birgelen C, de Vrey EA, Mintz GS, Nicosia A, Bruining N, Li W, et al. ECG-gated three-dimensional intravascular ultrasound: Feasibility and reproducibility of the automated analysis of coronary lumen and atherosclerotic plaque dimensions in humans. Circulation 1997; 96: 2944-2952.
22. Waseda K, Ako J, Yamasaki M, Koizumi T, Ormiston J, Worthley SG, et al. Short- and mid-term intravascular ultrasound analysis of the new zotarolimus-eluting stent with durable polymer: Results from the RESOLUTE trial. Circ J 2010; 74: 2097-2102.
23. Takagi T, Okura H, Kobayashi Y, Kataoka T, Taguchi H, Toda I, et al. A prospective, multicenter, randomized trial to assess efficacy of pioglitazone on in-stent neointimal suppression in type 2 diabetes: POPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study). JACC Cardiovasc Interv 2009; 2: 524-531.
24. Onuma Y, Serruys P, den Heijer P, Joesoef KS, Duckers H, Regar E, et al. MAHOROBA, first-in-man study: 6-Month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenoses. Eur Heart J 2009; 30: 1477-1485.
25. Verheye S, Agostoni P, Dubois CL, Dens J, Ormiston J, Worthley S, et al. 9-Month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: The DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study. J Am Coll Cardiol 2009; 53: 1031-1039.